Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy

Clin Res Cardiol. 2010 Jan;99(1):53-5. doi: 10.1007/s00392-009-0084-3. Epub 2009 Sep 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Cardiomyopathy, Hypertrophic / diagnosis
  • Cardiomyopathy, Hypertrophic / etiology
  • Echocardiography
  • Electrocardiography
  • Enzyme Replacement Therapy / methods*
  • Fabry Disease / drug therapy*
  • Fabry Disease / physiopathology
  • Female
  • Humans
  • Hypertrophy, Left Ventricular / diagnosis
  • Hypertrophy, Left Ventricular / etiology
  • Isoenzymes / therapeutic use*
  • alpha-Galactosidase / therapeutic use*

Substances

  • Isoenzymes
  • alpha-Galactosidase
  • agalsidase beta